These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 17446830)
1. Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002. Rose AJ; Backus BM; Gershman ST; Santos P; Ash AS; Battaglia TA Med Care; 2007 May; 45(5):440-7. PubMed ID: 17446830 [TBL] [Abstract][Full Text] [Related]
2. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Klabunde CN; Potosky AL; Harlan LC; Kramer BS Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657 [TBL] [Abstract][Full Text] [Related]
3. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts. Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer. Hamilton AS; Fleming ST; Wang D; Goodman M; Wu XC; Owen JB; Lo M; Ho A; Anderson RT; Thompson T Am J Clin Oncol; 2016 Feb; 39(1):55-63. PubMed ID: 24390274 [TBL] [Abstract][Full Text] [Related]
5. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Zeliadt SB; Potosky AL; Etzioni R; Ramsey SD; Penson DF Urology; 2004 Dec; 64(6):1171-6. PubMed ID: 15596192 [TBL] [Abstract][Full Text] [Related]
6. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. Hoffman RM; Harlan LC; Klabunde CN; Gilliland FD; Stephenson RA; Hunt WC; Potosky AL J Gen Intern Med; 2003 Oct; 18(10):845-53. PubMed ID: 14521648 [TBL] [Abstract][Full Text] [Related]
8. Treatment for older prostate cancer patients: disparities in a southern state. Pisu M; Oliver JS; Kim YI; Elder K; Martin M; Richardson LC Med Care; 2010 Oct; 48(10):915-22. PubMed ID: 20733530 [TBL] [Abstract][Full Text] [Related]
9. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA. Lediju O; Ikuemonisan J; Salami SS; Adejoro O J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310 [TBL] [Abstract][Full Text] [Related]
10. Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Schapira MM; McAuliffe TL; Nattinger AB Med Care; 1995 Nov; 33(11):1079-88. PubMed ID: 7475418 [TBL] [Abstract][Full Text] [Related]
11. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Nambudiri VE; Landrum MB; Lamont EB; McNeil BJ; Bozeman SR; Freedland SJ; Keating NL Urology; 2012 Mar; 79(3):537-45. PubMed ID: 22245306 [TBL] [Abstract][Full Text] [Related]
12. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. Moses KA; Paciorek AT; Penson DF; Carroll PR; Master VA J Clin Oncol; 2010 Feb; 28(6):1069-74. PubMed ID: 20100957 [TBL] [Abstract][Full Text] [Related]
13. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Morris CR; Snipes KP; Schlag R; Wright WE Cancer Causes Control; 1999 Dec; 10(6):503-11. PubMed ID: 10616820 [TBL] [Abstract][Full Text] [Related]
14. Marriage and ethnicity predict treatment in localized prostate carcinoma. Denberg TD; Beaty BL; Kim FJ; Steiner JF Cancer; 2005 May; 103(9):1819-25. PubMed ID: 15795905 [TBL] [Abstract][Full Text] [Related]
15. Hospital racial composition and the treatment of localized prostate cancer. Pollack CE; Bekelman JE; Liao KJ; Armstrong K Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067 [TBL] [Abstract][Full Text] [Related]
16. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer. Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115 [TBL] [Abstract][Full Text] [Related]
17. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database. Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ; Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204 [TBL] [Abstract][Full Text] [Related]
18. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. Hamilton AS; Albertsen PC; Johnson TK; Hoffman R; Morrell D; Deapen D; Penson DF BJU Int; 2011 Feb; 107(4):576-84. PubMed ID: 20735387 [TBL] [Abstract][Full Text] [Related]
19. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823 [TBL] [Abstract][Full Text] [Related]
20. A multidimensional view of racial differences in access to prostate cancer care. Pollack CE; Armstrong KA; Mitra N; Chen X; Ward KR; Radhakrishnan A; Wong MS; Bekelman JE; Branas CC; Rhodes KV; Grande DT Cancer; 2017 Nov; 123(22):4449-4457. PubMed ID: 28727136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]